{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:08:31Z","timestamp":1780088911911,"version":"3.54.0"},"reference-count":33,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder with well-documented effects on patients\u2019 quality of life (QoL). The aim of this study was to evaluate the QoL of patients with HS via the use of a newly developed questionnaire: Hidradenitis Suppurativa Quality of Life-24 (HSQoL-24). This study was performed on a population of 342 HS patients. Their QoL was assessed via the HSQoL-24 questionnaire. The perceived impairment of QoL due to HS in the studied group was considered to be serious (mean HSQoL-24 score: 58.3 \u00b1 21.0 points). Women tended to experience a significantly higher impact from the disease than men (61.6 \u00b1 19.2 points vs. 51.1 \u00b1 23.1 points, p &lt; 0.001). The HS severity had an effect on the perceived QoL, with statistically significant differences being evident between the self-assessed HS severity groups. The level of QoL impairment correlated positively with the number of affected body areas (r = 0.285, p &lt; 0.001) and the duration of the disease (r = 0.173, p = 0.001), while the patients\u2019 age at disease onset correlated negatively with the HSQoL-24 global score (r = \u22120.182, p = 0.001). Patients living in their family house scored higher than other groups. The least affected were patients who lived alone. The study shows that the HSQoL-24 questionnaire is a reliable, HS-specific tool for measuring the QoL among patients with HS in real-life clinical settings.<\/jats:p>","DOI":"10.3390\/jcm10225446","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:28Z","timestamp":1638314548000},"page":"5446","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Use of HSQoL-24 in an Assessment of Quality-of-Life Impairment among Hidradenitis Suppurativa Patients: First Look at Real-Life Data"],"prefix":"10.3390","volume":"10","author":[{"given":"Piotr K.","family":"Krajewski","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chalubinskiego Street 1, 50-368 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5632-0351","authenticated-orcid":false,"given":"Servando E.","family":"Marr\u00f3n","sequence":"additional","affiliation":[{"name":"Aragon Psychodermatology Research Group (GAI + PD), Dermatology Department, University Hospital Miguel Servet, 50009 Zaragoza, Spain"},{"name":"Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Paseo de Isabel la Catolica 1-3, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gomez-Barrera","sequence":"additional","affiliation":[{"name":"Pharmacoeconomics & Outcomes Research Iberia (PORIB), Campus Universitario, University of San Jorge, Autovia Mudejar Km. 299, Villanueva de Gallego, 50830 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-628X","authenticated-orcid":false,"given":"Luc\u00eda","family":"Tomas-Aragones","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Zaragoza, Calle Pedro Cerbuna 12, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-3617","authenticated-orcid":false,"given":"Yolanda","family":"Gilaberte-Calzada","sequence":"additional","affiliation":[{"name":"Aragon Psychodermatology Research Group (GAI + PD), Dermatology Department, University Hospital Miguel Servet, 50009 Zaragoza, Spain"},{"name":"Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Paseo de Isabel la Catolica 1-3, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chalubinskiego Street 1, 50-368 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000496923","article-title":"The Evolution of Quality of Life Assessment and Use in Dermatology","volume":"235","author":"Chernyshov","year":"2019","journal-title":"Dermatology"},{"key":"ref_2","first-page":"72","article-title":"Quality of life among dermatology patients: A systematic review of investigations using qualitative methods","volume":"154","author":"Singh","year":"2019","journal-title":"G. Ital. Dermatol. E Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jdv.13985","article-title":"Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life","volume":"31","author":"Finlay","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Del Duca, E., Morelli, P., Bennardo, L., Di Raimondo, C., and Nistic\u00f2, S.P. (2020). Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228436"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Krajewski, P., Matusiak, \u0141., von Stebut, E., Schultheis, M., Kirschner, U., Nikolakis, G., and Szepietowski, J. (2021). Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients. Life, 11.","DOI":"10.3390\/life11010034"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chernyshov, P., Finlay, A., Tomas-Aragones, L., Poot, F., Sampogna, F., Marron, S., Zemskov, S., Abeni, D., Tzellos, T., and Szepietowski, J. (2021). Quality of Life in Hidradenitis Suppurativa: An Update. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18116131"},{"key":"ref_8","first-page":"554","article-title":"Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa","volume":"110","author":"Rull","year":"2019","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"adv00529","DOI":"10.2340\/00015555-3905","article-title":"Quality of Life in Hidradenitis Suppurativa: Validation of the HSQoL","volume":"101","author":"Marron","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis Suppurativa\/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/1346-8138.12881","article-title":"Questionnaire surveillance of hidradenitis suppurativa in Japan","volume":"42","author":"Kurokawa","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","article-title":"The symptomatology of hidradenitis suppurativa in women","volume":"119","author":"Jemec","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne in-versa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical Aspects of Hidradenitis Suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jdv.16255","article-title":"Psychosocial burden of Hidradenitis Suppurativa patients\u2019 partners","volume":"34","author":"Matusiak","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional ac-tivity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.14922","article-title":"A pilot study of unemployment in patients with hidradenitis sup-purativa in Denmark","volume":"176","author":"Thorlacius","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Glowaczewska, A., Reszke, R., Szepietowski, J.C., and Matusiak, L. (2021). Indirect Self-Destructiveness in Hidradenitis Suppurativa Pa-tients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184194"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/bjd.16603","article-title":"Profound consequences of hidradenitis suppurativa: A review","volume":"183","author":"Matusiak","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases","volume":"133","author":"Chren","year":"1997","journal-title":"Arch. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"EuroQol-Group (1990). EuroQol\u2014A new facility for the measurement of health-related quality of life. Health Policy, 16, 199\u2013208.","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1684\/ejd.2019.3552","article-title":"Assessing the psychological burden of patients with hidradeni-tis suppurativa","volume":"29","author":"Frings","year":"2019","journal-title":"Eur. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00403-019-02025-5","article-title":"Factors affecting quality of life in patients with hid-radenitis suppurativa","volume":"312","author":"Holm","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa","volume":"232","author":"Kouris","year":"2016","journal-title":"Dermatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000496234","article-title":"Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument","volume":"5","author":"Thorlacius","year":"2019","journal-title":"Ski. Appendage Disord."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Krajewski, P., Matusiak, \u0141., Szepietowska, M., Rymaszewska, J., Jemec, G., Kirby, J., and Szepietowski, J. (2020). Hidradenitis Suppurativa Quality of Life (HiSQOL): Creation and validation of the Polish language version. Adv. Dermatol. Allergol. Post\u0119py Dermatol. I Alergol., 37.","DOI":"10.5114\/ada.2020.97064"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: Development and validation of a measure for clinical trials","volume":"183","author":"Kirby","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/CCID.S151114","article-title":"Vitiligo and social acceptance","volume":"11","author":"Bidaki","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5114\/pdia.2016.62286","article-title":"How does stigma affect people with psoriasis?","volume":"1","author":"Marcinkiewicz","year":"2017","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1203475416685078","article-title":"Atopic Dermatitis, Depression, and Suicidality","volume":"21","author":"Nicholas","year":"2017","journal-title":"J. Cutan. Med. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/22\/5446\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:52Z","timestamp":1760168032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/22\/5446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":33,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["jcm10225446"],"URL":"https:\/\/doi.org\/10.3390\/jcm10225446","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}